FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/060037 [Registered on: 20/11/2023] Trial Registered Prospectively
Last Modified On: 17/11/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Comparative Analysis Of The Effect Of Different Protein Intake and Resistance Training On Muscle Mass, Muscle Strength, And Fat Mass in Postmenopausal Women With Diabetes And Obesity. 
Scientific Title of Study   Pilot Real World Study on the Effects Of Different Protein Intake and Resistance Training on Muscle Mass, Muscle Strength, and Fat Mass in Postmenopausal Women with Diabetes and Obesity: A Comparative Analysis of Normal diet, 15g and 30g Protein Intake 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR SANJAY AGARWAL  
Designation  CONSULTANT PHYSICIAN  
Affiliation  RUBY HALL CLINIC 
Address  Ruby Hall Clinic, 40, Sasoon Road, Sangamwadi, Pune, Maharashtra, 411001
Department of Internal Medicine, Division of Diabetes and Metabolic Disorders, Room number- OPD 1
Pune
MAHARASHTRA
411001
India 
Phone  9822091220  
Fax    
Email  agarwalclinic@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SANJAY AGARWAL  
Designation  CONSULTANT PHYSICIAN  
Affiliation  RUBY HALL CLINIC 
Address  Ruby Hall Clinic, 40, Sasoon Road, Sangamwadi, Pune, Maharshtra, 411001
Department of Internal Medicine, Division of Diabetes and Metabolic Disorders, Room number- OPD 1
Pune
MAHARASHTRA
411001
India 
Phone  9822091220  
Fax    
Email  agarwalclinic@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SANJAY AGARWAL  
Designation  CONSULTANT PHYSICIAN  
Affiliation  RUBY HALL CLINIC 
Address  Ruby Hall Clinic, 40, Sasoon Road, Sangamwadi, Pune, Maharashtra, 411001
Department of Internal Medicine, Division of Diabetes and Metabolic Disorders, Room number- OPD 1
Pune
MAHARASHTRA
411001
India 
Phone  9822091220  
Fax    
Email  agarwalclinic@gmail.com  
 
Source of Monetary or Material Support  
Ruby Hall Clinic, 40, Sasoon Road, Sangamwadi, Pune, Maharashtra, 411001 
 
Primary Sponsor  
Name  RUBY HALL CLINIC 
Address  Department of Internal Medicine, Division of Diabetes and Metabolic Disorders, Room Number- OPD 1, 40,Sasoon Road, Sangamwadi, Pune, Maharashtra,411001  
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SANJAY AGARWAL   RUBY HALL CLINIC  Department of Internal Medicine, Division of Diabetes and Metabolic Disorders, Room number- OPD 1, 40, Sasoon Road, Sangamwadi, Pune, Maharashtra, 411001
Pune
MAHARASHTRA 
9822091220

agarwalclinic@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
POONA MEDICAL RESEARCH FOUNDATION  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E116||Type 2 diabetes mellitus with other specified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparative Analysis of Normal diet, 15g, and 30g Protein Intake- Effects of Different Protein Intake and Resistance Training on Muscle Mass, Muscle Strength, and Fat Mass in Postmenopausal Women with Diabetes and Obesity  Addition of Supplemental Protein of 15 grams and 30 grams to the normal diet. 
Intervention  Comparative Analysis of Normal diet, 15g, and 30g Protein Intake- Effects of Different Protein Intake and Resistance Training on Muscle Mass, Muscle Strength, and Fat Mass in Postmenopausal Women with Diabetes and Obesity  Standard diet consisting of the daily diet taken by the patients  
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  Post-menopausal women ages between 45 to 60 years are included with a history of Diabetes
BMI greater than or equal to 30 kg/ m²
HbA1C greater than or equal to 6.5%
 
 
ExclusionCriteria 
Details  WOMEN WHO ARE NOT WITHIN THE AGE GROUP OF 45 TO 60 YEARS
WOMEN WHO ARE NOT DIABETIC
eGFR LESSER THAN 60MM/HR
ANY MALIGNANCIES
TYPE 1 DIABETIES MELLITUS
WOMEN WHO HAVE PAIN SCORES  
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Assessing the Muscle Mass with regards to the changes made with the Protein Intake and the Resistance Training   The time period will be 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Assessing the Muscle Mass with regards to the changes made with the Protein intake & Resistance Training. We will be saving the blood transfusions for the detection of HbA1C values & will use it for the later phases of the trial.  Time period will be one year from now  
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   27/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will be conducted with 90 postmenopausal women  aged between 45 to 60 years old where in they will be divided into 3 groups for the trial. 
Each group will be sub-divided into 2 groups based on whether they received resistant training or not with a supplemental addition of protein in 15g and 30g.
This will be  to study the additional benefit of resistance training over protein supplementation. 
We will be hosting virtual training programs, and for the benefit of those unable to attend physically, consultation will be done online, and we will be archiving the video recordings for later access.

 
Close